[1]
Munir, M.S. et al. 2025. A Randomized Control Trial of Nitazoxanide Versus Rifaximin in Preventing the Recurrence of Hepatic Encephalopathy. Indus Journal of Bioscience Research. 3, 6 (Jun. 2025), 1314–1320. DOI:https://doi.org/10.70749/ijbr.v3i6.2868.